lidocaine and Endometrial Diseases

lidocaine has been researched along with Endometrial Diseases in 6 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Research

Studies (6)

Authors

Clinical Trials (2)

Trial Overview

Trial Outcomes

Difference in Postoperative Pain Using a Visual Analog Scale at 2 Hours.

"At approximately two hours postoperatively patients completed a visual analog scale (VAS), which was a 10-cm numeric scale on which 0 represented no pain and 10 represented the worst pain ever." (NCT00746863)
Timeframe: 2 hours postoperative from mid-urethral sling placement

Difference in Postoperative Pain Using a Visual Analog Scale at 24 Hours.

"At approximately twenty-four hours postoperatively patients completed a visual analog scale (VAS), which was a 10-cm numeric scale on which 0 represented no pain and 10 represented the worst pain ever." (NCT00746863)
Timeframe: 24 hours postoperative from mid-urethral sling placement

Difference in Postoperative Pain Using a Visual Analog Scale at 6 Hours.

"At approximately six hours postoperatively patients completed a visual analog scale (VAS), which was a 10-cm numeric scale on which 0 represented no pain and 10 represented the worst pain ever." (NCT00746863)
Timeframe: 6 hours postoperative from mid-urethral sling placement

Difference in Successful Voiding Trial Prior to Discharge Following Placement of Mid-urethral Sling Via the Suprapubic Approach.

Prior to discharge, patients underwent voiding trials. At our institution, in order to pass the voiding trial, they must void at least 200 cc spontaneously and have less than 100 cc as a post void residual two times in a row. (NCT00746863)
Timeframe: From after surgery to discharge from hospital.

In-hospital Medication Amounts

Secondary outcome included differences in amount of pain medication used in the hospital. This was assessed by comparing the number of pills of oral narcotics the patient took while hospitalized. (NCT00746863)
Timeframe: From surgery until discharge, average

Pain During IUD Placement

"IUD was inserted following the manufacturer's instructions, and a pain score was immediately obtained. Pain was scored on 0-9 scale; with 0 being no pain and 9 being worst pain in life." (NCT01311102)
Timeframe: Immediately after IUD placement

Pain During Tenaculum Placement

"Pain score on 0-9 scale for tenaculum placement (without anesthesia); with 0 being no pain and 9 being worst pain in life. Taken to adjust for different pain thresholds among subjects" (NCT01311102)
Timeframe: Immediately following tenaculum placement

Pain Measurement During Liquid Infusion/Sounding

"After liquid infused into three parts of the endometrial cavity: in the lower one third, the middle, and at the top of the cavity. Pain was scored on a 0-9 scale; with 0 being no pain and 9 being worst pain in life." (NCT01311102)
Timeframe: Recorded at the end of the infusion

Pain Scores During Overall IUD Placement

"Pain score on 0-9 scale obtained just before the patient left the examination room; with 0 being no pain and 9 being worst pain in life." (NCT01311102)
Timeframe: Before patient left the examination room at conclusion of procedure

Trials

4 trials available for lidocaine and Endometrial Diseases

Other Studies

2 other studies available for lidocaine and Endometrial Diseases